Scilex Holding SCLX
NASDAQ SCLX
$5.20 -0.17 (-3.17%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scilex Holding (SCLX) Other Non-Current Liabilities (2020 - 2026)

Scilex Holding (SCLX) posted Other Non-Current Liabilities of $81.5 million for Q2 2026, up 8.65% on a QoQ basis from $75.0 million in Q1 2026, and up 19.99% year-over-year from $67.9 million in Q2 2025.

Analysis

Scilex Holding (SCLX) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Scilex Holding has reported Other Non-Current Liabilities for 7 years, with the latest figure at $81.5 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 19.99% year-over-year to $81.5 million in Q2 2026; TTM through Jun 2026 was $81.5 million, a 19.99% increase from a year earlier, with the FY2025 full-year figure at $107.4 million, up 76.08% from the prior year.
  • Other Non-Current Liabilities was $81.5 million for Q2 2026 at Scilex Holding, up from $75.0 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $146.6 million in Q3 2025, with the low at $1.2 million in Q3 2022.
  • Average Other Non-Current Liabilities over 5 years is $65.8 million, with a median of $71.4 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities tumbled 96.1% in 2022, then jumped 10004.15% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $1.4 million in 2022, then jumped by 7800.0% to $110.1 million in 2023, then sank by 44.63% to $61.0 million in 2024, then surged by 76.08% to $107.4 million in 2025, then declined by 24.12% to $81.5 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $81.5 million (Q2 2026), $75.0 million (Q1 2026), and $107.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Scilex Holding 38.06 Mn -76.90 Mn 3.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.48 Mn
Mar 31, 2026 75.00 Mn
Dec 31, 2025 107.37 Mn
Sep 30, 2025 146.58 Mn
Jun 30, 2025 67.91 Mn
Mar 31, 2025 54.79 Mn
Dec 31, 2024 60.98 Mn
Sep 30, 2024 96.24 Mn
Jun 30, 2024 117.29 Mn
Mar 31, 2024 100.05 Mn
Dec 31, 2023 110.13 Mn
Sep 30, 2023 117.49 Mn
Jun 30, 2023 25.18 Mn
Mar 31, 2023 16.25 Mn
Dec 31, 2022 1.39 Mn
Sep 30, 2022 1.16 Mn
Jun 30, 2022 1.23 Mn
Mar 31, 2022 3.76 Mn
Dec 31, 2021 35.70 Mn
Sep 30, 2021 4.86 Mn